Bio Protocol vs Maple Finance — how do they compare? Bio Protocol trades at Rp442.42 (market cap Rp999,88M, Rp161,38M 24h volume), while Maple Finance trades at Rp2,724 (market cap Rp3,25T, Rp84,3M 24h volume). The key difference: Maple Finance is far larger — about 3250.4× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Maple Finance's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Maple Finance for 14 Days on average.
| BIO | SYRUP | |
|---|---|---|
Market Cap | Rp999,88M | Rp3,25T |
Volume (24h) | Rp161,38M | Rp84,3M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1,2B SYRUP |
Typical Hold Time | 18 Days | 14 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
SYRUP is trading at Rp2,763 with a market cap of Rp3.29T, showing a bearish technical signal as moving averages indicate selling pressure while oscillators are neutral. Key support lies at Rp2,549 and resistance at Rp2,801. No major protocol updates or ecosystem news were found recently.
The outlook is cautious due to bearish technicals and lack of fundamental catalysts. Opportunities include potential bounces from support levels, but risks involve low liquidity and high volatility. Investors should monitor for any new ecosystem developments.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Maple, launched in 2021, is an on-chain asset manager that combines decades of experience in traditional finance and cryptocurrency. By merging capital markets expertise with DeFi innovation, Maple offers a variety of products, including secured lending, Bitcoin yield strategies, and structured financial instruments.
Read more on SYRUP →